
Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Puma Biotechnology and CANbridge Pharmaceuticals Terminate License Agreement in Greater China LOS ANGELES & CASTRES, France–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and […]
